New Dermatology Company Resilia Pharmaceuticals Begins Operations Atlanta-based Specialty Pharma Company Is Focused on Patient Outcomes Peak Pharma Commercial Partners, a New York City-based ...

CAIRO, April 18, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA ...

Resilia, a tech company that services nonprofit organizations and the organizations that want to donate to them, has announced an $8 million Series A funding round. It’s the highest venture capital ...

NEWBURY, July 25 2025 – Edwards Lifesciences today announced that it has received CE Mark for its KONECT RESILIA aortic valved conduit (AVC), the first ready-to-implant solution with RESILIA ...

(RTTNews) - Edwards Lifesciences Corp. (EW) has received approval from the U.S. FDA for the KONECT RESILIA aortic valved conduit, the first ready-to-implant solution for bio-Bentall procedures. The ...

Nonprofits often struggle with allocating their resources and funding to have the greatest impact. Sevetri Wilson knew she could take ideas and execute them, so she created her platform, Resilia, to ...

Global major in patient-focused innovation for structural heart disease and critical care monitoring, Edwards Lifesciences Corporation EW is making constant efforts to expand its Surgical Heart Valve ...